Literature DB >> 17086463

N-95 face mask for prevention of bird flu virus: an appraisal of nanostructure and implication for infectious control.

Viroj Wiwanitkit1.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 17086463      PMCID: PMC7087815          DOI: 10.1007/s00408-006-0021-4

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


× No keyword cloud information.
Bird flu or avian flu, caused by the H5N1 virus, is a new emerging infectious disease. There has been a worldwide problem regarding avian influenza infections in poultry since 1997. It is noted that this H5N1 virus jumped the species barrier and caused severe disease with high mortality in humans in Vietnam and Thailand (http://www.thaigcd.ddc.moph.go.th/avianflu_FAQ_en.html). For prevention of airborne viral infection, N-95 masks are the gold standard that might be applicable to the bird flu infection [1]. Because most viruses are approximately spherical, the virus is modeled as a sphere moving through the mask’s pore [2]. Its motion is influenced by convection in the carrier fluid, by diffusion, and by short-range interactions with the pore walls [2]. Interactions that trap the virus against the pore wall are the primary barrier to transmission [2]. This concept can be used for predicting transmission of the avian flu virus via eggshell. In this article the author analyzed the feasibility of avian flu virus passing through the N-95 mask by taking nanostructure level into consideration. The basic concept is that if the size of the virus is larger than the pore size of the N-95 mask, the virus cannot pass through the pores [2]. The author searched for the size of the virus and the pores of the N-95 mask in the literature. According to the search, the size of the pores of the N-95 mask is about 300-500 nm in diameter [5] and the size of the avian flu virus is about 100 nm (http://www.users.rcn.com/jkimball.ma.ultranet/BiologyPages/I/Influenza.html). Based on the particle size as a single factor, the pore size of the N-95 mask is about 3–5 times larger than the size of the virus. The author hereby proposes that the transmission on the avian flu virus through the N-95 mask is feasible. Indeed, the possibility that SARS, a virus of similar size to the avian flu, can pass through the N-95 mask has also been reported [4]. In addition, the N-95 mask also has about a 10% leakage problem around the mask [3]. It should also be noted that N-95 masks, at best, provide a seal with external leakage in the 3%–5% range. This assumes that the wearer of the mask has been properly fitted for the mask and is wearing the mask properly. The amount of inspired air that would bypass the filter and be brought around the filter and into the respiratory tract may be considerably larger. This is most apparent in individuals who are not wearing a mask correctly or who are not adequately trained in the proper fit of an N-95 mask. This is particularly problematic for family members and nonmedical personnel who may wish to use N-95 masks to prevent transmission of respiratory viruses. Therefore, there is no doubt about the possibility of the avian flu virus passing through the N-95 mask. However, transmission through the N-95 mask does not mean a person will be infected. There are many other factors that contribute to infection. In addition, influenza transmission generally occurs through small aerosol particles in the range of 1-10 μm in diameter. It is possible that individual virions are transmitted person to person, but most transmissions occur in small aggregates of viruses that would be effectively blocked by an N-95 mask. Using a mask does reduce the risk of infection compared with not using a mask. Also, the general universal precautions, especially washing the hands after contact with a person with respiratory infection, should be followed.
  4 in total

1.  The best protection.

Authors:  John H Lange
Journal:  CMAJ       Date:  2003-06-10       Impact factor: 8.262

2.  SARS respiratory protection.

Authors:  John H Lange
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

3.  Laboratory performance evaluation of N95 filtering facepiece respirators, 1996.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1998-12-11       Impact factor: 17.586

4.  Performance of N95 respirators: reaerosolization of bacteria and solid particles.

Authors:  Y Qian; K Willeke; S A Grinshpun; J Donnelly
Journal:  Am Ind Hyg Assoc J       Date:  1997-12
  4 in total
  7 in total

1.  MERS-CoV, surgical mask and N95 respirators.

Authors:  Viroj Wiwanitkit
Journal:  Singapore Med J       Date:  2014-09       Impact factor: 1.858

2.  Authors' Reply. MERS-CoV, surgical mask and N95 respirators.

Authors:  Jasmine Shimin Chung; Moi Lin Ling; Wing Hong Seto; Brenda Sze Peng Ang; Paul Anantharajah Tambyah
Journal:  Singapore Med J       Date:  2014-09       Impact factor: 1.858

3.  Ostrich produce cross-reactive neutralization antibodies against pandemic influenza virus A/H1N1 following immunization with a seasonal influenza vaccine.

Authors:  Kazuhide Adachi; Kentaro Takama; Masaya Tsukamoto; Marie Inai; Ekowati Handharyani; Satoshi Hiroi; Yasuhiro Tsukamoto
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

4.  Protection from avian influenza H5N1 virus infection with antibody-impregnated filters.

Authors:  Yoichiro Kamiyama; Kazuhide Adachi; Ekowati Handharyani; Retno Damajanti Soejoedono; Takayuki Kusano; Marie Inai; Masaya Tsukamoto; Seizaburo Kashiwagi; Yasuhiro Tsukamoto
Journal:  Virol J       Date:  2011-02-08       Impact factor: 4.099

5.  The spread of influenza and other respiratory viruses: complexities and conjectures.

Authors:  Caroline Breese Hall
Journal:  Clin Infect Dis       Date:  2007-06-19       Impact factor: 9.079

6.  The SARS-CoV-2 outbreak from a one health perspective.

Authors:  Maged Gomaa Hemida; Mohammed M Ba Abduallah
Journal:  One Health       Date:  2020-03-16

Review 7.  How effective is a mask in preventing COVID-19 infection?

Authors:  Yuxin Wang; Zicheng Deng; Donglu Shi
Journal:  Med Devices Sens       Date:  2021-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.